WB

William Brady

BS Bristol-Myers Squibb: 18 patents #272 of 3,969Top 7%
ES Emergent Product Development Seattle: 3 patents #4 of 15Top 30%
AD Aptevo Research And Development: 2 patents #17 of 24Top 75%
AM Ambrx: 1 patents #68 of 85Top 80%
Pfizer: 1 patents #3,022 of 5,153Top 60%
📍 Bothell, WA: #74 of 2,342 inventorsTop 4%
🗺 Washington: #3,196 of 76,902 inventorsTop 5%
Overall (All Time): #152,202 of 4,157,543Top 4%
26
Patents All Time

Issued Patents All Time

Showing 1–25 of 26 patents

Patent #TitleCo-InventorsDate
12059473 Humanized anti-prostate -specific membrane antigen (PSMA) antibody drug conjugates Shivarupam Bhowmik, Jianing Wang, Jinming Xia, Feng Tian 2024-08-13
10307481 CD37 immunotherapeutics and uses thereof Laura Sue Grosmaire, Martha Hayden-Ledbetter, Jeffrey A. Ledbetter, Peter Armstrong Thompson, Sandy Alexander Simon 2019-06-04
10202447 Antibody derivatives Kenneth H. Grabstein, Gordon King, Natalie Winblade Nairn, Kurt Shanebeck, Paul Heffner Slagle +4 more 2019-02-12
10143748 B-cell reduction using CD37-specific and CD20-specific binding molecules Laura Sue Grosmaire, Martha Hayden-Ledbetter, Jeffrey A. Ledbetter, Peter Armstrong Thompson, Sandy Alexander Simon 2018-12-04
9884921 Bispecific heterodimeric diabodies and uses thereof Chad May, Adam Reid Root, Lioudmila Tchistiakova, Lidia Mosyak, Laird Bloom +2 more 2018-02-06
9101609 CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof Philip Tan, Sandy Alexander Simon, Charles G. Cerveny, Christy Anne Nilsson, Jeffrey A. Ledbetter +3 more 2015-08-11
8409577 Single chain multivalent binding proteins with effector function Peter Armstrong Thompson, Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Laura Sue Grosmaire, Robert F. Bader 2013-04-02
8333966 CD37 immunotherapeutics and uses thereof Philip Tan, Sandy Alexander Simon, Cecile Morales 2012-12-18
7572772 Soluble CTLA4 mutant molecules Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle, Philip M. Wallace 2009-08-11
7311910 Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle 2007-12-25
7105166 Soluble CTLA4 mutant molecules and uses thereof Peter S. Linsley, Jeffrey A. Ledbetter, Jurgen Bajorath, Robert James Peach, Philip M. Wallace +1 more 2006-09-12
7070776 Methods for blocking binding of CD28 receptor to B7 Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle 2006-07-04
6887471 Method to inhibit T cell interactions with soluble B7 Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle 2005-05-03
6830937 Method for generating and identifying antibodies directed against a B7 Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle 2004-12-14
6641809 Method of regulating cellular processes mediated by B7 and CD28 Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle 2003-11-04
6090914 CTLA4/CD28Ig hybrid fusion proteins and uses thereof Peter S. Linsley, Jeffrey A. Ledbetter, Jurgen Bajorath, Robert James Peach 2000-07-18
5977318 CTLA4 receptor and uses thereof Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle, Peter Kiener 1999-11-02
5968510 CTLA4 receptor and uses thereof Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle, Peter Kiener 1999-10-19
5885579 CTLA4 receptor and uses thereof Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle, Peter Kiener 1999-03-23
5885796 CTLA4 receptor and uses thereof Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle 1999-03-23
5851795 Soluble CTLA4 molecules and uses thereof Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle, Peter Kiener 1998-12-22
5844095 CTLA4 Ig fusion proteins Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle 1998-12-01
5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle, Philip M. Wallace 1998-06-23
5580756 B7IG fusion protein Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle 1996-12-03
5521288 CD28IG fusion protein Peter S. Linsley, Jeffrey A. Ledbetter, Nitin K. Damle 1996-05-28